Remdesivir in a pregnant patient with COVID-19 pneumonia

Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non...

Descripción completa

Detalles Bibliográficos
Autores principales: Dande, Ranadheer, Qureshi, Anum, Persaud, Kia, Puri, Chahat, Zulfiqar, Sajida, Awasthi, Shankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7850401/
https://www.ncbi.nlm.nih.gov/pubmed/33552429
http://dx.doi.org/10.1080/20009666.2020.1857510
Descripción
Sumario:Remdesivir is an antiviral drug currently being studied as a potential treatment of pneumonia caused by infection with SARS-CoV-2. The Adaptive Covid-19 Treatment Trial (ACTT-1) by NIH and the SIMPLE study by Gilead Sciences are two major trials that showed promising results of Remdesivir in the non-pregnant population. We are presenting the case of a pregnant patient who was diagnosed with COVID-19 pneumonia and successfully treated with Remdesivir.

Ejemplares similares